Literature DB >> 22296978

Characterization and study of piperazinium salts, degradation products of nitrogen mustards by nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry.

Jin Young Lee1, Yong Han Lee, Yong Gwan Byun.   

Abstract

We synthesized and analyzed the degradation products, piperazinium salts from bis(2-chloroethyl)methylamine (HN2) and bis(2-chloroethyl)ethylamine (HN1) using ¹H nuclear magnetic resonance (NMR) and liquid chromatography-mass spectrometry (LC-MS). Piperazinium salt is the major degradation product of HN2, not N-methyldiethanolamine above a concentration of 0.01 M in water and is a non-scheduled chemical that may be generally assumed relevant to the Chemical Weapons Convention (CWC) within the context of the Organization for the Prohibition of Chemical Weapons (OPCW) proficiency test. In verification analysis, ¹H NMR offers real-time information about degradation pathway of nitrogen mustards and LC-MS is expected to play an increasing role in the analysis of environmental samples for the degradation products of chemical warfare agents. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296978     DOI: 10.1016/j.chroma.2011.12.107

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Characterization and Study on Fragmentation Pathways of a Novel Nerve Agent, 'Novichok (A234)', in Aqueous Solution by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Jin Young Lee; Kyoung Chan Lim; Hyun Suk Kim
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

2.  Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity.

Authors:  D Maciejewska; J Żabiński; M Rezler; P Kaźmierczak; M S Collins; L Ficker; M T Cushion
Journal:  Medchemcomm       Date:  2017-10-05       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.